Skip to content
★ Sign in to follow
Tdspharm Co., Ltd. logo

Tdspharm Co., Ltd. Stock: price and insider trades · South Korea

티디에스팜

KR·Mcap ₩21.4BHealth Care

No insider purchase over the last 90 days. The latest, by 김철준, was filed 24 Jun 2026.

Tdspharm Co., Ltd.: what insiders have been doing

Tdspharm Co., Ltd. belongs to the Health Care sector. Filings by its managers are published through DART (FSS). In the past year (9 November 2025 to 9 November 2026), 4 filings came from 1 insider.

The flow runs one way only: 1 insider bought (4 purchases) and nobody sold on the market. The totals do not cover 4 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 1 major shareholder and 1 chief executive.

Across the 2,657 companies tracked on its exchange, the median is 7 filings; at 4 filings, this issuer sits below that mark. Looking back to 2024, when coverage begins, insiders filed 14 purchases and 2 sales.

The most recent open-market purchase was published on 24 June 2026, 139 days ago.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. Source: insider filings from DART (FSS). Past trades are no guide to future returns.

Insider Decl.
16
Thresholds
n/a
Buy Volume
€391,013
14 ops. · all time
Sell Volume
€405,032
2 ops. · all time

Who traded when

BuySale
김철준8 buys
한국증권금융1 buy1 sale
Fundamental score
Ranked 7,102 of 26,911 companies
63.4
score / 100
Value
63
Quality
63
FCF yld-43%
Earn yld20%
EV/EBITDA4.9x
ROE12%
Gross mgn27%
Net mgn15%
Debt/EBITDA1.3x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩4,040
Analyst consensus
·
Income statement
Revenue₩27.6B
Gross profit₩7.5B27% margin
EBITDA₩5.9B21% margin
Net income₩4.3B15.7% margin
Valuation
Beta0.44
Balance sheet & cash
Market cap₩21.4B
Total debt₩7.7B
Free Cash Flow-₩9.1B
Debt / Equity31%
Profitability & ownership
ROE12.2%
ROA6.2%
% insiders46.6%
% institutions0.0%
Last declaration on 24 June 2026
Declarations21 total
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ▲
    대표이사Executives(filed)
    €8,373est.0DART
    2,476 sharesShareKRXDART:20260624000156
    Canonical exit: 22 Sept 2026 (T+90)
  • ▲
    대표이사Executives(filed)
    €2,836est.0DART
    750 sharesShareKRXDART:20260618000112
    Canonical exit: 16 Sept 2026 (T+90)
  • ▲
    대량보유자Executives(filed)
    €21kest.0DART
    5,422 sharesKRXDART:20260618000110
    Canonical exit: 16 Sept 2026 (T+90)
  • ▲
    Executives
    €68kest.0DART
    11,586 sharesKRXDART:20260109000295
    Canonical exit: 5 Apr 2026 (T+90)
  • ▲
    대표이사Executives(filed)
    €12kest.0DART
    2,000 sharesShareKRXDART:20250902000149
    Canonical exit: 1 Dec 2025 (T+90)
  • ▲
    대량보유자Executives
    €12kest.0DART
    2,000 sharesKRXDART:20250902000136
    Canonical exit: 1 Dec 2025 (T+90)
  • ▲
    대량보유자Executives
    €18kest.0DART
    2,400 sharesKRXDART:20250502000278
    Canonical exit: 31 Jul 2025 (T+90)
  • ▲
    대표이사Executives(filed)
    €18kest.0DART
    2,400 sharesShareKRXDART:20250502000191
    Canonical exit: 31 Jul 2025 (T+90)
  • ▼
    Related company / holdingExecutives
    €405kest.0DART
    60,141 sharesKRXDART:20250409001816
  • ▲
    Related company / holdingExecutives
    €231kest.0DART
    25,290 sharesKRXDART:20250109000129
    Canonical exit: 6 Mar 2025 (T+90)
  • 272,881 sharesKRXDART:20240930000456
  • ▲
    Executives
    0DART
    2,535,100 sharesKRXDART:20240828000788
    Canonical exit: 19 Nov 2024 (T+90)
  • 290,611 sharesKRXDART:20240828000762
    Canonical exit: 19 Nov 2024 (T+90)
  • ▲
    대표이사Executives
    0DART
    ShareKRXDART:20240827000365
    Canonical exit: 19 Nov 2024 (T+90)
  • ▲
    CFOExecutives
    0DART
    ShareKRXDART:20240826000416
    Canonical exit: 19 Nov 2024 (T+90)
  • ▲
    BD managerExecutives
    0DART
    ShareKRXDART:20240826000426
    Canonical exit: 19 Nov 2024 (T+90)

21 of 21 declarations

About Tdspharm Co., Ltd.

티디에스팜 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development and commercialization of pharmaceutical products.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations